Sandra Levy
ARTICLES BY THIS AUTHOR
- 12/8/2019
Amgen gets FDA nod for biosimilar Remicade
Amgen's biosimilar Avsola offers a biological treatment option to patients across critical disease states, including chronic inflammatory conditions. - 12/8/2019
OptumRx acquires Diplomat Pharmacy
Diplomat and OptumRx's combination will expand the innovative specialty pharmacy and infusion solutions that OptumRx can offer. - 12/5/2019
FDA approves first 3 generics of Gilenya
The FDA has approved three applications for first generics of Novartis’ Gilenya (fingolimod) capsules for relapsing forms of multiple sclerosis in adult patients. - 12/5/2019
Automation, tech companies rethink pharmacy pain points
Pharmacy technology and automation companies are stepping up to the plate to ensure that pharmacists can juggle their roles successfully. - 12/5/2019
Dr. Reddy's debuts 2 generics
Exjade had a market value of roughly $113 million and Jadenu had a market value of about $470 million for the most recent 12 months ended in September. - 12/5/2019
KPH Healthcare Services, Citizen Advocates to provide behavioral health pharmacy care
Kinnect is a transformational on-site pharmacy option for community health centers, which offers mental health and addiction services. - 12/3/2019
Blink Health offers free medications on various prescriptions
Blink Health is offering new patients more than 4,000 medications for free. - 12/2/2019
Amneal launches 3 generics
Amneal has received the Food and Drug Administration’s clearance for three generics that it is introducing immediately, including the first generic of Carafate (sucralfate oral suspension). - 12/2/2019
Lupin launches generic Westcort cream
Hydrocortisone valerate cream 0.2% had a market value of roughly $11.5 million, according to IQVIA September 2019 data. - 12/2/2019
RxSense announces executive appointments
Vishal Arora and Nitin Shingate are joining RxSense as chief technology officers for its enterprise and consumer divisions, respectively.
